Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December 21, 2021 Provided by The Consortium of Multiple Sclerosis Centers and International Organization of Multiple Sclerosis Nurses and Spire Learning. This activity is supported by an educational grant from Genentech, a member of the Roche Group. PRIMARY AUDIENCE: This multidisciplinary educational initiative is targeted to …

Advancing the Role of the Nurse in the Management of MS in Rural Areas: An Online Curriculum

This online curriculum provides up-to-date information related to the comprehensive care of people living with multiple sclerosis (MS) in rural areas. Led by expert faculty with extensive experience in both MS care and rural health, it is designed to address the unique challenges faced by nursing professionals practicing in rural areas. Many of these challenges …

What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis

RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December 30, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — maximum of 1.0 contact hours of continuing nursing …

IJMSC: I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis

Release Date: December 1, 2020 Valid for Credit Through: December 1, 2021 I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis Anne Christin Rahn, PhD; Alessandra Solari, MD; Heleen Beckerman, PhD; Richard Nicholas, PhD; David Wilkie, PhD; Christoph Heesen, MD; Andrea Giordano, MSc; for the Rehabilitation …

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October 21, 2021 Neuromyelitis optica spectrum disorder (NMOSD) is an inflammatory disorder of the central nervous system characterized by immune-mediated demyelination and axonal damage predominantly targeting the optic nerves and spinal cord. To provide the most up-to-date information on the diagnosis and treatment of NMOSD, the …

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by The Consortium of Multiple Sclerosis Centers and Catamount Medical Education. This activity is supported by an independent education grant from Sanofi Genzyme. Credit Available Physicians — maximum of 1.0 AMA PRA Category 1 Credit(s)™ Nurses — 1.0 Nursing Contact Hours Pharmacists — 1.0 Contact Hours (.1 CEUs) All other …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 1: FUNDAMENTALS OF CANNABIS RELEASE DATE: October 20, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use cannabis. However, numerous surveys indicate that …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 2: CANNABIS AS AN HERBAL MEDICINE – EFFICACY/SIDE EFFECT CONSIDERATIONS AND CASE STUDIES RELEASE DATE: October 27, 2020 VALID FOR CREDIT THROUGH: October 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with …

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION 3: PHARMACOLOGY AND INTERACTIONS, TRIAL DATA, DMTs, AND CASE STUDIES RELEASE DATE: NOVEMEBER 11, 2020 VALID FOR CREDIT THROUGH: OCTOBER 31, 2021 SERIES DESCRIPTION MS health professionals may be involved in the decision-making process about cannabis and provide care to those with MS who use …

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited by the Consortium of Multiple Sclerosis Centers (CMSC) and Haymarket Medical Education (HME). Supported by an educational grant from Bristol Myers Squibb. Intended Audience Neurologists and other physicians, nurse practitioners, PAs, registered nurses, and pharmacists who collaborate to provide care for patients with MS Program …